Graham Capital Management, L.P. Harmony Biosciences Holdings, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 10,523 shares of HRMY stock, worth $367,357. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,523
Previous 25,764
59.16%
Holding current value
$367,357
Previous $865,000
63.35%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding HRMY
# of Institutions
233Shares Held
45.2MCall Options Held
48.2KPut Options Held
56.5K-
Valor Management LLC Chicago, IL11.2MShares$392 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$123 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$91 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$87.6 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.07B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...